Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

alpelisib

(AL-peh-LIH-sib)
A drug used with fulvestrant to treat postmenopausal women, and men, with hormone-receptor positive, HER2-negative breast cancer that is advanced or has spread and has a mutation (change) in the PIK3CA gene. It is used in patients whose cancer got worse during or after treatment with hormone therapy. It is also being studied in the treatment of other types of cancer. Alpelisib blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of kinase inhibitor. Also called Piqray.
More Information
Search NCI's Dictionary of Cancer Terms